Long-acting muscarinic antagonists (LAMA) added to inhaled corticosteroids (ICS) versus addition of long-acting beta2-agonists (LABA) for adults with asthma-Reference-Cited by-全球学者库

Long-acting muscarinic antagonists (LAMA) added to inhaled corticosteroids (ICS) versus addition of long-acting beta2-agonists (LABA) for adults with asthma

Published:2015-06-02 Issue: Volume: Page:
ISSN:1465-1858
Container-title:Cochrane Database of Systematic Reviews
language:en
Short-container-title:

Author:

Kew Kayleigh M¹,Evans David JW²,Anderson Debbie E³,Boyter Anne C³

Affiliation:

1. BMJ; British Medical Journal Technology Assessment Group (BMJ-TAG); BMA House Tavistock Square London UK WC1H 9JR

2. Lancaster University; Lancaster Health Hub; Lancaster UK LA1 4YG

3. University of Strathclyde; Strathclyde Institute of Pharmacy and Biomedical Sciences; Glasgow UK

Publisher

Wiley

Subject

Pharmacology (medical)

Reference99 articles.

1. Tiotropium is noninferior to salmeterol in maintaining improved lung function in B16-Arg/Arg patients with asthma;Bateman;Journal of Allergy and Clinical Immunology,2011

2. NCT00350207 A 16-week randomised, placebo-controlled, double-blind, double-dummy, parallel-group study comparing the efficacy and safety of tiotropium inhalation solution delivered by the Respimat Inhaler (2 actuations of 2.5 mcg once daily) with that of salmeterol from the hydrofluoroalkane metered dose inhaler (2 actuations of 25 mcg twice daily) in moderate persistent asthma patients with the B16-Arg/Arg genotype clinicaltrials.gov/show/NCT00350207

3. Tiotropium bromide in asthma patients: an alternative to inhaled long-acting beta-agonists?;Lane;Journal of the Royal College of Physicians of Edinburgh,2010

4. NCT00565266 Asthma Clinical Research Network (ACRN) Trial - Tiotropium bromide as an alternative to increased inhaled corticosteroid in patients inadequately controlled on a lower dose of inhaled corticosteroid (TALC) clinicaltrials.gov/show/NCT00565266

5. Predictors of response to tiotropium versus salmeterol in asthmatic adults;Peters;Journal of Allergy and Clinical Immunology,2013

Cited by 32 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Addition of long-acting beta2 agonists or long-acting muscarinic antagonists versus doubling the dose of inhaled corticosteroids (ICS) in adolescents and adults with uncontrolled asthma with medium dose ICS: a systematic review and network meta-analysis;Cochrane Database of Systematic Reviews;2023-08-21

2. Optimizing asthma management: Role of long-acting muscarinic antagonists;Journal of Allergy and Clinical Immunology;2022-09

3. Tiotropium as an add‑on treatment to inhaled corticosteroids in children with severe and mild symptomatic asthma: Multi‑center observational study for efficacy and safety analysis;Experimental and Therapeutic Medicine;2022-07-19

4. Sabit doz inhale kortikosteroid, uzun etkili beta-2 agonist ve uzun etkili muskarinik reseptör antagonisti (İKS/LABA/LAMA) kombinasyonunun astım tedavisindeki yeri;Tuberk Toraks;2021-09-22

5. Extracellular adenosine 5′-triphosphate in pulmonary disorders;Biochemical Pharmacology;2021-05